EXEMPTIA 40MG

Exemptia 40mg Injection contains Adalimumab, a biologic medication classified as a tumor necrosis factor (TNF) inhibitor. It is specifically designed to manage and alleviate symptoms associated with various autoimmune and inflammatory disorders. Adalimumab works by targeting TNF-alpha, a substance in the body that plays a central role in promoting inflammation. By inhibiting TNF-alpha, Exemptia reduces inflammation, joint damage, and related symptoms such as pain, swelling, and stiffness.

This injection is commonly prescribed for conditions such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. It also plays a vital role in treating inflammatory bowel diseases like Crohn’s disease and ulcerative colitis, as well as non-infectious uveitis and hidradenitis suppurativa.

Before starting therapy, it’s important to undergo screening for latent infections, particularly tuberculosis, as TNF inhibitors can increase susceptibility to serious infections. You should avoid using Exemptia if you have an active infection, a history of recurring infections, or moderate to severe heart failure. During treatment, regular monitoring by a healthcare provider is essential, especially for signs of infection, liver or kidney impairment, and any unusual symptoms.

Women who are pregnant, planning to conceive, or breastfeeding should discuss the potential risks and benefits with their doctor. As with all biologic therapies, adherence to dosing schedules and close medical supervision is crucial for safe and effective treatment.